Psychoactive substance use during the COVID-19 pandemic

Toxicological implications from a comprehensive approach and therapeutic challenges

Abstract

Mr. Director of the Revista Médica del Uruguay
Prof. Dr. Hugo Rodríguez

In the context of the COVID-19 pandemic, it is necessary to understand the potential changes in patterns of alcohol consumption, psychotropic drugs, major pain relievers, and the occasional or experimental use of other central nervous system depressant, stimulant, or disruptive drugs "to alleviate displeasure ”. In conditions of isolation, consumption can be aggravated, far from a socio-affective network or from adequate treatment, even more so when the evidence shows that in conditions prior to the pandemic, problem drug users have greater difficulties in accessing drugs. healthcare services (1)